1. Role of EFNA1 in tumorigenesis and prospects for cancer therapy
   Yongping Hao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
2. EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance
   Ling-Yu Chu et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
3. Monoclonal Antibodies in Cancer Therapy
   David Zahavi et al, 2020, Antibodies CrossRef
4. Targeting EphA2 in cancer
   Ta Xiao et al, 2020, Journal of Hematology & Oncology CrossRef
5. Cell Death, by Any Other Name…
   Mustapha Kandouz, 2024, Cells CrossRef
6. EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
   Mario Cioce et al, 2021, Cancers CrossRef
7. EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner
   Azadeh Arabzadeh et al, 2017, Oncotarget CrossRef
8. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets
   João Figueira Scarini et al, 2024, Frontiers in Oncology CrossRef
9. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
   Rafaela Nasser Veiga et al, 2024, Journal of Molecular Medicine CrossRef
10. The EPH/Ephrin System in Colorectal Cancer
    Stavros P. Papadakos et al, 2022, International Journal of Molecular Sciences CrossRef
11. Molecular genetics of congenital cataracts
    Jinyu Li et al, 2020, Experimental Eye Research CrossRef
12. Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
    Lucien Torlot et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef